Type IV myocardial infarction associated with acute stent thrombosis in the early period after revascularization in a patient with new coronavirus infection COVID-19

New facts suggest that COVID-19 coronavirus infection is partly mediated by hypercoagulability reactions characterized by micro- and macrovascular thrombotic angiopathy, which leads to acute myocardial injury, myocarditis, arrhythmias and numerous cases of pulmonary thromboembolic disease . The article presents a clinical observation of acute myocardial infarction development as a result of early thrombosis of an implanted coronary stent in a patient diagnosed with a new coronavirus infection COVID-19.

1. Akchurin R.S., Shiryaev A.A., Galyautdinov D.M. Indications for coronary bypass surgery in patients with different course of coronary artery disease. Russian Medical Journal. 2012;10(19):871–873. (in Russian)]

2. Windecker S., Kolh P., Alfonso F. et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur. Heart J. 2014;35:2541–619. DOI: 10.1093/eurheartj/ehu278

3. Camenzind E., Steg P.G., Wijns W. Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. Circulation. 2017;115:1440–55. DOI: 10.1161/CIRCULATIONAHA.106.666800

4. Joner M., Finn A.V., Farb A. et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J. Am. Coll. Cardiol. 2016;48:193–202. DOI: 10.1016/j.jacc.2006.03.042

5. Cutlip D.E., Baim D.S., Ho K.K. et al. Stent thrombosis in the modern era: A pooled analysis of multicenter coronary stent clinical trials. Circulation. 2011;103:1967–1971. DOI: 10.1161/01.cir.103.15.1967

6. Spiezia L., Boscolo A., Poletto F. COVID-19-Related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure. Thromb. Haemost. 2020;120:998–1000. DOI: 10.1055/s-0040-1710018

7. Azouz E., Yang S., Monnier-Cholley L. Systemic arterial thrombosis and acute mesenteric ischemia in a patient with COVID-19. Intensive Care Med. 2020;46:1464–1465. DOI: 10.1007/s00134-020-06079-2

8. Harari R., Bangalore S., Chang E. et al. COVID‐19 complicated by acute myocardial infarction with extensive thrombus burden and cardiogenic shock. Catheter Cardiovasc. Interv. 2020:10.1002/ccd.28992. DOI: 10.1002/ccd.28992

9. COVID-19: Myocardial infarction and other coronary artery disease issues. [Electronic resource] URL: https://www.uptodate.com/contents/covid-19-myocardial-infarction-and-other-coronary-artery-disease-issues.

10. Modin D, Claggett B, Sindet-Pedersen C, et al. Acute COVID-19 and the Incidence of Ischemic Stroke and Acute Myocardial Infarc tion. Circulation. 2020;142:2080. DOI: 10.1161/CIRCULATIONAHA.120.050809

11. Stefanini G.G., Montorfano M., Trabattoni D., et al. St-Elevation myocardial infarction in patients with COVID-19: clinical and angiographic outcomes. Circulation. 2020;141:2113–6. DOI: 10.1161/CIRCULATIONAHA.120.047525

12. Bangalore S., Sharma A., Slotwiner A. St-Segment elevation in patients with COVID-19: a case series. N. Engl. J. Med. 2020. DOI:10.1056/NEJMc2009020

13. Welt F.G.P., Shah P.B., Aronow H.D. et al. Catheterization laboratory considerations during the coronavirus (COVID-19) pandemic: from the ACC's interventional Council and ScaI. J. Am. Coll. Cardiol. 2020;75:2372–5. DOI: 10.1016/j.jacc.2020.03.021

14. Musher D.M., Abers M.S., Corrales-Medina V.F. Acute Infection and Myocardial Infarction. N. Engl. J. Med. 2019;380:171. DOI: 10.1056/NEJMra1808137

15. Ferrante G., Fazzari F., Cozzi O. et al. Risk factors for myocardial injury and death in patients with COVID-19: insights from a cohort study with chest computed tomography.  Cardiovascular Research. 2020;116(14):2239–2246. DOI: 10.1093/cvr/cvaa193